| Literature DB >> 30886857 |
Kemal Karapınar1, Celalettin İbrahim Kocatürk1.
Abstract
BACKGROUND: The rate of surgical site infections (SSIs) has decreased in parallel to advances in sterilization techniques. Such infections increase morbidity and hospitalization costs. The use of iodine-impregnated sterile wound drapes (SWDs) is recommended to prevent or reduce the incidence of these infections. However, there is a paucity of data regarding their use in thoracic surgical procedures. The aim of the present study was to evaluate the effectiveness of sterile wound drapes in the prevention of these infections and the effects on hospitalization costs.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30886857 PMCID: PMC6388313 DOI: 10.1155/2019/1438793
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Draped surgical site with iodine-impregnated drape.
Demographic characteristics and previous illness of patients.
| Control Group n:274 | Study Group n:380 | p | |||
|---|---|---|---|---|---|
| Age | 60.03±11.72 | 58.24±12.14 | 0.06 | ||
| Gender | |||||
| Male | 219 | 79.93% | 307 | 80.79% | 0.784+ |
| Female | 55 | 20.07% | 73 | 19.21% | |
| Morbidity (DM, HT, etc.) | 80 | 29.20% | 103 | 27.11% | 0.557+ |
| Previous hospitalization | 8 | 2.92% | 20 | 5.26% | 0.144+ |
Demographic characteristics of the participating patients.
| Control Group n:274 | Study Group n:380 | p | OR | |||
|---|---|---|---|---|---|---|
| Length of Stay in the Intensive Care Unit (days) | 1.33±1.25 | 1.48±2.48 | 0.590 | |||
| Operation Time (mins) | 222.08±68.95 | 268.94±92.17 |
| 1.01 (1.00-1.03) | ||
| CRP | 18.56±12.72 | 19.3±13.55 | 0.617 | |||
| Cost | 5942±2740 | 4813±1996 |
| 0.83 (0.78-0.98) | ||
| Length of Hospital Stay (days) | 8.69±4.65 | 8.21±5.12 | 0.093 | |||
| Blood Usage | 1.08±2.03 | 2.53±2.31 |
| 1.56 (1.39-1.75) | ||
| SSI | 25 | 9.12% | 11 | 2.90% |
| 0.30 (0.14-0.61) |
| VAC | 10 | 3.65% | 3 | 0.79% |
| 0.21 (0.06-0.77) |
| Blood Culture | ||||||
| Absent | 256 | 93.43% | 362 | 95.26% | 0.311+ | 1.41(0.72-2.77) |
| Present | 18 | 6.57% | 18 | 4.74% | ||
| Sputum Culture | ||||||
| Absent | 260 | 94.89% | 363 | 95.53% | 0.706+ | 1.15 (0.55-32.37) |
| Present | 14 | 5.11% | 17 | 4.47% | ||
| Wound Culture | ||||||
| Absent | 256 | 93.43% | 372 | 97.89% |
| 3.27 (0.40-7.63) |
| Present | 18 | 6.57% | 8 | 2.11% | ||
| Wound Debridement Culture | ||||||
| Absent | 263 | 95.99% | 378 | 99.47% |
| 7.91(1.74-35.97) |
| Present | 11 | 4.01% | 2 | 0.53% | ||
∗Independent samples t-test, ǂ: Mann-Whitney U test + Chi-square test, SSI: Surgical Site Infections, and VAC: Vacuum Assisted Closure.
Distribution of the operation types in the control and study groups.
| Control Group n:274 | Study Group n:380 | p | |||
|---|---|---|---|---|---|
| Operation | |||||
| Lung resection and mediastinal lymph node resection | 188 | 68.61% | 265 | 69.74% |
|
| Bronchial sleeve lobectomy | 2 | 0.73% | 17 | 4.47% | |
| Bronchovascular sleeve lobectomy | 1 | 0.36% | 8 | 2.11% | |
| Extended lung resections | 75 | 27.37% | 68 | 17.89% | |
| Lung resections after neoadjuvant chemoradiotherapy | 8 | 2.92% | 22 | 5.79% | |